These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 19398542)
21. Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum. Zeng H; Gong S; Hou S; Zou Q; Zhong G Infect Immun; 2012 Mar; 80(3):1098-106. PubMed ID: 22158739 [TBL] [Abstract][Full Text] [Related]
22. Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection. Wang L; Zhu C; Zhang T; Tian Q; Zhang N; Morrison S; Morrison R; Xue M; Zhong G Infect Immun; 2018 Feb; 86(2):. PubMed ID: 29133348 [No Abstract] [Full Text] [Related]
23. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. Jupelli M; Guentzel MN; Meier PA; Zhong G; Murthy AK; Arulanandam BP J Immunol; 2008 Mar; 180(6):4148-55. PubMed ID: 18322226 [TBL] [Abstract][Full Text] [Related]
24. Differences in innate immune responses correlate with differences in murine susceptibility to Chlamydia muridarum pulmonary infection. Jiang X; Shen C; Yu H; Karunakaran KP; Brunham RC Immunology; 2010 Apr; 129(4):556-66. PubMed ID: 20102413 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection. Scurlock AM; Frazer LC; Andrews CW; O'Connell CM; Foote IP; Bailey SL; Chandra-Kuntal K; Kolls JK; Darville T Infect Immun; 2011 Mar; 79(3):1349-62. PubMed ID: 21149587 [TBL] [Abstract][Full Text] [Related]
26. The contribution of interleukin-12/interferon-gamma axis in protection against neonatal pulmonary Chlamydia muridarum challenge. Jupelli M; Selby DM; Guentzel MN; Chambers JP; Forsthuber TG; Zhong G; Murthy AK; Arulanandam BP J Interferon Cytokine Res; 2010 Jun; 30(6):407-15. PubMed ID: 20187773 [TBL] [Abstract][Full Text] [Related]
37. Induction of protective immunity against Chlamydia muridarum intravaginal infection with a chlamydial glycogen phosphorylase. Li Z; Lu C; Peng B; Zeng H; Zhou Z; Wu Y; Zhong G PLoS One; 2012; 7(3):e32997. PubMed ID: 22427926 [TBL] [Abstract][Full Text] [Related]
38. Role of TRAIL-R in Primary and Secondary Genital and Respiratory Chlamydia muridarum Infections in Mice. Pal S; Sheff S; Al-Kuhlani M; Ojcius DM; de la Maza LM Microbiol Spectr; 2022 Aug; 10(4):e0161722. PubMed ID: 35876584 [TBL] [Abstract][Full Text] [Related]
39. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology. Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133 [TBL] [Abstract][Full Text] [Related]
40. IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis. Frazer LC; Scurlock AM; Zurenski MA; Riley MM; Mintus M; Pociask DA; Sullivan JE; Andrews CW; Darville T Am J Reprod Immunol; 2013 Dec; 70(6):472-84. PubMed ID: 24238108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]